{"DataElement":{"publicId":"5775593","version":"2","preferredName":"Person Iobenguane I-131 Administered Weight Value","preferredDefinition":"The weight value used for the calculation of the I-131 MIBG dose administered.","longName":"PSN_MIBG_I131_ADMN_WT","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"5775592","version":"2","preferredName":"Person Iobenguane I-131 Administered","preferredDefinition":"A human being._An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine._The act of having given something (e.g., a medication or test).","longName":"2236731v1.0:8027655v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2236731","version":"1","preferredName":"Person","preferredDefinition":"A human being.","longName":"C25190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Person","conceptCode":"C25190","definition":"A human being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FC6DF7-66EB-4CAB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-20","endDate":null,"createdBy":"UMLLOADER_MAGE","dateCreated":"2005-06-20","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"8027655","version":"1","preferredName":"Iobenguane I-131 Administered","preferredDefinition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.:The act of having given something (e.g., a medication or test).","longName":"C970:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iobenguane I-131","conceptCode":"C970","definition":"An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Iobenguane localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7211AA6-A8FF-3163-E053-4EBD850AF7B8","latestVersionIndicator":"Yes","beginDate":"2022-02-03","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-03","modifiedBy":"ONEDATA","dateModified":"2022-02-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008541","version":"1","preferredName":"Numbers","preferredDefinition":"the set of non-negative integers.","longName":"NUMS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B227CE66-2830-4A7B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D7211AA6-A8DC-3163-E053-4EBD850AF7B8","latestVersionIndicator":"Yes","beginDate":"2017-04-13","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-03","modifiedBy":"TITARENI","dateModified":"2022-02-03","changeDescription":"Workflow and Registration Status Changed per Brenda Duggan; 05.16.18; Created a version 2.0 where the concept \"weight\" is removed since it is already present within the VD_02/03/22_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2179445","version":"2","preferredName":"Weight Value","preferredDefinition":"The numerical result of the determination of the vertical force exerted by the mass of an individual as a result of gravity.","longName":"WT_VAL","context":"DCP","contextVersion":"1","type":"Non-enumerated","dataType":"NUMBER","minLength":null,"maxLength":"7","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008552","version":"1","preferredName":"Physical Description of Individuals","preferredDefinition":"general description of an individual's physical appearance and vital status.","longName":"PHYS_DESC_OF_INDS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B241CFD7-077D-1374-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-20","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-20","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2542099","version":"1","preferredName":"Weight Value","preferredDefinition":"The vertical force exerted by a mass as a result of gravity.:A numerical quantity measured or assigned or computed.","longName":"C25208:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Weight","conceptCode":"C25208","definition":"The vertical force exerted by a mass as a result of gravity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"223A280A-64BD-59D2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"DCP:Division of Cancer Prevention","workflowStatus":"RELEASED","registrationStatus":"Application","id":"223A280A-64CE-59D2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"MAESKEB","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2013-07-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Weight used for I-131 MIBG ad","type":"Preferred Question Text","description":"Weight used for I-131 MIBG administration:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D720A765-E1DE-1CBD-E053-4EBD850AA961","latestVersionIndicator":"Yes","beginDate":"2017-04-13","endDate":null,"createdBy":"TITARENI","dateCreated":"2022-02-03","modifiedBy":"TITARENI","dateModified":"2022-02-03","changeDescription":"02/03/2022 updated the CDE with v.2.0 DEC d/t semantic changes and updated the CDE version as well_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}